Pricing Log in Create free account
Friday 6 November 2026 Export TAK’s income statement to Excel — free account

Takeda Pharmaceutical Co.

TAK Healthcare Drug Manufacturers Specialty & Generic

Takeda Pharmaceutical Co.’s revenue for fiscal 2026 (year ended March 2026) was $29.7 billion, down 1.66% from fiscal 2025.

Revenue
+1.71%
EPS
−4.35%
Free cash flow
+54.9%
Total debt
−7.28%

Quarter to September 2026, against a year earlier

21.03 0.16 −0.76%
Market cap
$67.7B
P/E
32.0×
Fwd P/E
—
Dividend yield
1.45%
F-score
4/9
Altman Z
1.03
Beneish M
−2.65
Dividend safety
25/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Takeda Pharmaceutical Co. (TAK) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Takeda Pharmaceutical Co. (TAK) trades at a P/S ratio of 2.2×. Over the past ten years it has ranged from 1.3× (October 2022) to 3.1× (January 2018); the current reading is higher than 72% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 2.1× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2026 1.9× 22.39%
FY2025 1.6× 9.08%
FY2024 1.5× (15.29%)
FY2023 1.7× 21.74%
FY2022 1.4× (25.72%)
FY2021 1.9× 21.54%
FY2020 1.6× (18.77%)
FY2019 1.9× (20.06%)
FY2018 2.4× 0.97%
FY2017 2.4× 3.44%

Quarterly newest first

Period P/S ratio Change
Jun 2026 1.7× 4.24%
Jun 2025 1.6× 16.86%
Jun 2024 1.4× (4.64%)
Mar 2024 1.5× (3.73%)
25 more quarters

Against its own ten years

Low 1.3× High 3.1×
Ten-year median 1.8×
Current reading's percentile 78

P/S ratio against peers

Company P/S ratio
VTRS Viatris Inc. compare 1.5×
TAK Takeda Pharmaceutical Co. 2.2×
HLN Haleon PLC Sponsored ADR compare 2.3×
ELAN Elanco Animal Health Incorporated compare 2.4×
TEVA Teva Pharmaceutical Industries Ltd. compare 2.8×
ZTS Zoetis Inc. compare 3.6×
RDY Dr. Reddy's Laboratories Ltd compare 3.6×
NBIX Neurocrine Biosciences, Inc. compare 4.4×
UTHR United Therapeutics Corporation compare 7.6×
Drug Manufacturers Specialty & Generic industry median 2.1×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on TAK